Differential diagnosis of neurodegenerative diseases is a great challenge for both clinic practice and research. We investigated the ability of magnetic resonance spectroscopy (1H-MRS) of Posterior Cingulate Cortex (PCC) and brain volume asymmetries to differentiate patients with Primary Progressive Aphasia (PPA) from patients with Alzheimer’s disease (AD). The N-acetyl-aspartate to myo-inositol ratio (NAA/mI ratio) in the PCC discriminates APP from AD (p = 0.009) with an accuracy of 75.5%. Furthermore, ROC curve analyses of all statistically significant asymmetry indexes were performed and the PCC showed the highest level of accuracy (81.4%) in discriminating between the two neurodegenerative groups.
This abstract and the presentation materials are available to members only; a login is required.